VOYAGER THERAPEUTICS INC. - COMMON STOCK

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

13 мар 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

28 фев 2024 13:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

26 фев 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

21 фев 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research

20 фев 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference

07 фев 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Pricing of Public Offering

04 янв 2024 19:45:43 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Proposed Public Offering

04 янв 2024 13:14:15 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 янв 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies

02 янв 2024 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program

06 дек 2023 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results

06 ноя 2023 13:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

30 окт 2023 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference

25 сен 2023 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 сен 2023 13:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Participate in Upcoming Investor Conferences

30 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 авг 2023 13:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer

07 авг 2023 05:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results

03 авг 2023 04:00:01 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference

02 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire